We talk drugs and anti-capitalism with anthropology PhD candidate, Hilary Agro. Ranging from prohibition to psychedelic clinical trials and beyond, we explore the overlaps and differences in our analyses of the current psychedelic (and broader drug policy) landscape.

The Castalia Foundation — originally founded in part by Timothy Leary — "resurfaced" in 2020 with anti-mask content, praise for Donald Trump, and paranoid discussion around the sexual abuse of children. 

The Psymposia staff reflects on some of the books that kept us company throughout 2020, which we'd like to recommend to our readers for 2021. The list includes works of intersectional analysis, psychedelic history, surveillance capitalism, and more. We hope you appreciate these insights as much as we do.

'Debbie and Doug Drop Acid in the Desert' director, Scott Brown, talks mind-altering drugs, creating psychedelic visual effects, and dealing with depression.

All the financial conflict disclosures from Psychedelics Science 2023 speakers, in one handy list.

Rather than unpacking the actual causes of Lykos Therapeutics' disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health.

During a Psymposia investigation into the alarming 5-MeO-DMT practices of Dr. Martin Ball, Mark Haden announced his resignation from MAPS Canada.

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”

“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.

Why are some drugs legal and other drugs illegal? It's not based on science or the relative risks – but has everything to do with who is associated with them.